ALX Oncology Holdings Inc header image

ALX Oncology Holdings Inc

ALXO

Equity

ISIN null / Valor 55754366

UTP NYSE Arca (2026-09-03)

USD 2.03-2.40%

ALX Oncology Holdings Inc
UMushroom community rating:

3.00 1 votes No rating yet

NegativeNeutralPositive

About company

ALX Oncology Holdings Inc is a publicly traded, clinical‑stage biotechnology company focused on developing immuno‑oncology therapies that modulate innate and adaptive immune checkpoints to enhance anti‑tumor responses. Its lead program is a CD47‑pathway targeted biologic designed to enable immune‑mediated clearance of cancer cells while minimizing hematologic toxicity, and the company advances this and other candidates in combination with checkpoint inhibitors and tumor‑directed antibodies across solid tumors and hematologic malignancies. ALX’s strategy centers on progressing these programs through clinical trials, pursuing regulatory approval pathways and strategic collaborations to commercialize therapies if clinical results support efficacy and safety.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

99.0%1Y

-55.1%3Y

-97.2%5Y

Performance

96.1%1Y

109%3Y

98.6%5Y

Volatility

281 M

Market cap (USD)

603,425

Daily traded volume (Shares)

1.695 / 1.55

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.00

1 votes

Performance:

3.00

Innovation:

3.00

Society:

3.00

Nature:

3.00

Matthias Bittel

Switzerland, 11 Mar 2025

Ganz ok

EQUITIES OF THE SAME SECTOR

Ypsomed Holding AG

Ypsomed Holding AG Valor: 1939699

Annual Return

-50%0%+50%

Risk level

110

-2.70%CHF 395.80

Aster DM Healthcare Ltd.

Aster DM Healthcare Ltd. Valor: 40341147

Annual Return

-50%0%+50%

Risk level

110

3.25%INR 786.90

Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd Valor: 758744

Annual Return

-50%0%+50%

Risk level

110

-0.71%USD 36.36

Ramsay Generale de Sante SA

Ramsay Generale de Sante SA Valor: 1247709

Annual Return

-50%0%+50%

Risk level

110

-2.73%EUR 10.70

IQVIA Holdings Inc

IQVIA Holdings Inc Valor: 39103858

Annual Return

-50%0%+50%

Risk level

110

-1.42%USD 267.77

Robertet SA

Robertet SA Valor: 510354

Annual Return

-50%0%+50%

Risk level

110

1.14%EUR 797.00

Janux Therapeutics Inc

Janux Therapeutics Inc Valor: 111742522

Annual Return

-50%0%+50%

Risk level

110

0.51%USD 19.80

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252587

Annual Return

-50%0%+50%

Risk level

110

-0.59%DKK 44.12

Embla Medical hf

Embla Medical hf Valor: 1060135

Annual Return

-50%0%+50%

Risk level

110

-0.86%DKK 28.75

H. Lundbeck A/S

H. Lundbeck A/S Valor: 119252584

Annual Return

-50%0%+50%

Risk level

110

-0.23%DKK 43.85

SIX

FactSet

Clearbit

Logos provided by Clearbit